Thelansis

  Bronchopulmonary dysplasia (BPD), is a chronic respiratory disease that most often occurs in low-weight or premature infants who have received supplemental oxygen or have spent long periods of time on a breathing machine (mechanical ventilation), such as infants who have acute respiratory distress syndrome. Etiology- Most BPD cases affect premature infants (preemies), usually those who are born more than 10 weeks early and weigh less than 4.5 pounds (2,000 grams). These babies are more likely to develop RDS (also called hyaline membrane disease), which is a result of tissue damage to the lungs from being on a mechanical ventilator for a long time. Epidemiology- The National Institutes of Health estimates that 10,000-15,000 babies born in the United States develop BPD each year.   The competitive landscape of Bronchopulmonary Dysplasia (BPD) includes country-specific approved as well as pipeline therapies. Any asset/product-specific designation or review and Accel...